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Kala-azar (KA) is a life-threatening protozoal disease caused by Leishmania parasites (L. donovani, L. chagasi,
and L. infantum). The disease, which is also called “visceral leishmaniasis,” is prevalent in Africa, South America,
Asia, and the Mediterranean basin. Epidemics occur periodically, killing a large number of infected individuals.
Factors determining whether a patient remains asymptomatic or develops KA are still largely unknown. In a previous
study that was performed during an outbreak of KA in a village on the Ethiopian-Sudanese border, we showed
that KA was more frequent in certain families and ethnic groups, thereby suggesting that host genetic factors play
an important role in the development of the disease. Here, we report the results of a genomewide linkage study
performed on 63 Sudanese families selected from the most affected ethnic group and including 169 children with
KA. Significant linkage (LOD score 3.50 [ ] in all patients; LOD score 3.90 [ ] in patients55 55Pp 3# 10 Pp 10
who were affected early in the outbreak) was obtained with markers on chromosome 22q12. These results are the
first evidence of a major genetic effect on the development of human KA. They may lead to identification of genes
critical in the pathogenesis of this disease and to new therapeutic interventions against this parasite, which is
developing resistance to available drugs.
Introduction
Visceral leishmaniasis is a disease caused by protozoa of
the Leishmania donovani complex (L. donovani, L. ar-
chibaldi, and L. infantum/chagasi). Leishmania, which are
introduced into their human hosts by sand flies, rapidly
invade macrophages, where they multiply inside phago-
lysosomes. Human infections may be asymptomatic (i.e.,
subclinical) or may cause a severe visceral disease that is
called “kala-azar” (KA) (Southgate and Manson-Bahr
1967; Badaro et al. 1986a, 1986b; Zijlstra et al. 1994).
Clinical manifestations of KA include recurrent fever,
hepatosplenomegaly, general lymphadenopathy, pan-
cytopenia, and anemia; death occurs in the absence of
appropriate chemotherapy (Pearson and Sousa 1996).
Major KA outbreaks have occurred in India and the Su-
dan in recent years and have killed thousands of people
(Seaman et al. 1996).
Factors that determine whether an infection remains
asymptomatic or progresses to KA are largely unknown.
Epidemiological studies have identified some environ-
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mental factors that affect exposure to Leishmania (Des-
jeux 1996, 2001). They have also indicated that the
development of KA in infected individuals may de-
pend on familial and ethnic factors (Zijlstra et al.
1994; Cabello et al. 1995; Ibrahim et al. 1999), sug-
gesting that inherited factors may determine suscepti-
bility to the disease in exposed populations. Genetics of
infection by Leishmania has been studied in mice, and
mutations in the Nramp1 gene (Bradley et al. 1979;
Vidal et al. 1995) and the H-2 locus (Blackwell et al.
1980) were shown to affect the multiplication of L.
donovani. The possibility that susceptibility to KA may
be increased by mutations in certain genetic loci is also
supported by experimental studies on L. major infec-
tions, which cause cutaneous leishmaniasis (CL) (Rob-
erts et al. 1993; Demant et al. 1996; Beebe et al. 1997).
Attempts to identify genes involved in susceptibility to
leishmaniasis in humans have focused on candidate-
gene testing (Blackwell 1996); associations have been
reported between some HLA alleles (Barbier et al. 1987;
Lara et al. 1991; Petzl-Erler et al. 1991) and TNF gene
polymorphisms (Cabrera et al. 1995) and the risk of
cutaneous and mucocutaneous leishmaniasis; however,
the relevance of genetic susceptibility to KA has not yet
been established.
Our group has undertaken a longitudinal study in a
population during an outbreak of KA in a Sudanese
village during 1995–2002. The seroepidemiological sur-
veys, performed at different times, showed that almost
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Table 1
Distribution of Families Acording to the Number of Sibs with KA
FAMILY
NO. OF FAMILIES WITH
TOTAL
Two
Affected
Sibs
Three
Affected
Sibs
Four
Affected
Sibs
Five
Affected
Sibs
First set (primary scan) 17 14 5 2 38
Second set 15 8 1 1 25
Total 32 22 6 3 63
NOTE.—All families were from the Aringa ethnic group and lived in the village
of Barbar El Fugara (eastern Sudan).
all the population has been exposed to infection (Buch-
eton et al. 2003b) and that ∼25% of inhabitants have
been affected by KA. Familial clustering of KA cases
and differences in disease prevalence between ethnic
groups indicated that this population was suitable for
studies aimed at identifying susceptibility loci (Bucheton
et al. 2002). A few candidate chromosomal regions were
tested by linkage analysis on affected sib pairs, and sug-
gestive linkage (LOD score 1.08; ) was observedPp .01
with a CA repeat in the NRAMP1 gene promoter (Buch-
eton et al. 2003). We have now performed a genome-
wide search on this population and have identified a
susceptibility locus for KA on chromosome 22q12
(LOD score 3.5; ) and suggestive evidence5Pp 3# 10
of a second locus, on chromosome 2.
Material and Methods
Subjects and Families
Study subjects are from the village of Barbar El Fugara
in eastern Sudan. The population of this village com-
prises mostly migrants from West Africa (members of
the Hausa and Fellata ethnic groups) and the western
Sudan/Chad area (members of the Aringa ethnic group),
who started to settle as agricultural laborers in the
1940s. An outbreak of KA caused by L. donovani, L.
infantum, and L. archibaldi (Pratlong et al. 2001) oc-
curred in the village from 1995 to 2002 (El-Safi et al.
2002). All affected study subjects met the following three
criteria for the diagnosis of KA: (i) presence of any two
of the clinical symptoms (persistent fever, splenomegaly,
general lymphadenopathy, loss of weight, and anemia);
(ii) presence of parasites in lymph node aspirate; and (iii)
positive response to treatment with Glucantime (Specia
Rhone-Poulenc) or Pentostam (Wellcome Foundation).
A seroepidemiological survey (Bucheton et al. 2003b)
indicated that 90% of the village population harbored
Leishmania-specific antibodies in the third year of the
outbreak (1998). Twenty-eight percent of the village
population developed KA during this outbreak, and
most cases (90%) occurred in subjects 30 years old
(Bucheton et al. 2002).
To reduce genetic heterogeneity in the study sample,
only Aringa families (280 individuals from 63 families)
were included. The 63 nuclear families selected for the
study were not fully independent, since they were ascer-
tained in 42 large pedigrees. The number of affected sib-
lings who were genotyped is shown in table 1. The 63
families included 169 affected subjects (84 females; 85
males; age range 5–30 years [mean age 12.6 years]). Four
subjects were ill in 1995, 29 in 1996, 73 in 1997, 33 in
1998, 24 in 1999, and 6 in 2000. Both parents were
available in 39 families; only one parent was available in
20 families; and no parents were available in 4 families.
When available, unaffected siblings were included, to infer
the missing parents’ genotypes ( ). Thirty-eightNp 13
families were studied in the first stage of this genomewide
linkage scan, and the 25 remaining families were included
only in the second stage (table 1).
The study protocol was approved by both the federal
and state Ministries of Health and by the Faculty of
Medicine of Khartoum. Informed consent was obtained
from the district authorities, from the village committee,
from all participating adults, and from the parents of
the children in the study. The regional health authorities
and the village committee were informed on each of our
visits of the purpose of the visit and the progress of the
work.
Genotyping
The marker set used in the present study contained
367 microsatellite markers from the ABI Prism Linkage
Mapping Set (MD10), version 2 (PE Biosystems), and
20 additional microsatellite markers (Dib et al. 1996).
Three NRAMP1 gene (2q35) polymorphisms—5′(CA)n,
46914G/C, and 172955del4—were also typed, as
described elsewhere (Liu et al. 1995). Genotyping of
microsatellite markers was performed as follows. DNA
was extracted from blood samples according to a stan-
dard salting-out method. PCR assays with fluorescence-
labeled primers were performed in 10-ml reactions con-
taining genomic DNA (40 ng) and were set up with an
automated pipetting station (Hamilton Microlab 4200).
The DNA was amplified with each primer pair sepa-
rately, pooled into panels, and run on ABI 377 sequenc-
ers (PE Biosystems), along with a size-standard ladder
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Figure 1 Annual incidence of KA during Barbar El Fugara village
outbreak, according to ethnic group and age. A, Annual incidence of
KA for subjects !30 years old, who represented 90% of the total KA
cases. B, Annual incidence of KA for subjects !20 years old (circles)
and for subjects 130 years old (triangles).
(ROX or TAMRA; Applied Biosystems). The gels were
analyzed using the Genescan analysis 3.1 and Genotyper
2.1 programs. Mendelian transmission of marker alleles
was checked, and data from outlying individuals were
either corrected or discarded before statistical analysis.
Statistical Analyses
Linkage analysis was performed using the maximum-
likelihood binomial (MLB) model-free method (Abel et
al. 1998). The approach is based on the binomial dis-
tribution of the number of affected siblings that have
received a given parental allele, and it does not need to
break down sibships with more than two affected into
constitutive sibpairs. The likelihood of the data depends
on only one parameter, which is denoted as “a” and is
the probability parameter of this binomial distribution.
There is a direct relationship between a and the pro-
portion of alleles shared by the affected sibs, which is
equal to 1–2a(1a), regardless of the number of af-
fected sibs (Abel et al. 1998). The a parameter is esti-
mated by maximum-likelihood calculations, and the test
for linkage is a simple likelihood-ratio test that assesses
the departure of a from 0.5. The resulting statistic is
asymptotically distributed as a 50:50 mixture of distri-
butions with 0 and 1 df and can be expressed as a LOD
score that has the same distribution as a LOD score
based on a classical model that estimates the recombi-
nation fraction. Multipoint development of the MLB has
been implemented (Abel and Muller-Myhsok 1998) in
an extension of the Genehunter program (Kruglyak et
al. 1996), and large simulation studies showed that the
MLB statistic provided very consistent type I errors when
asymptotic distributions were used, particularly in the
analysis of families with more than two affected siblings
(Abel and Muller-Myhsok 1998).
The locus-specific sibling recurrence-risk ratio (ls) was
estimated by using the commonly used relationship be-
tween ls and the proportion of affected sibpairs sharing
zero alleles (Risch 1990).
Results
KA affected only one-third of the village population, but
190% of the subjects were seropositive at the end of the
outbreak; the transmission occurred in the village itself,
most probably inside the huts (Lambert et al. 2002).
Large differences in KA incidence were observed be-
tween ethnic groups, and incidence was highest in Aringa
households (fig. 1A): 34.3% of the Aringa who were
!30 years old developed the disease, compared with
10.1% and 14.6% for the Hausa and Fellata, respec-
tively. As observed in other KA outbreaks, children and
teenagers had the highest risk of developing the disease,
particularly during the first years of the outbreak; KA
was more frequent in adults toward the end of the out-
break (fig. 1B). Furthermore, most subjects who devel-
opped KA in 1999 or 2000 were seropositive for 1 or
2 years before the onset of disease (Bucheton et al.
2003b); this suggests long periods of asymptomatic car-
riage in these subjects.
A genomewide linkage study was performed on af-
fected siblings, who were selected mainly from the most
affected age groups (children and teenagers), and their
parents. To reduce genetic heterogeneity of the study
sample, only Aringa families were included. The linkage
study was conducted in two steps. First, 38 families with
multiple KA-affected siblings (table 1) were genotyped
for 367 microsatellite markers covering the whole ge-
nome and providing a 10–15-cM primary genetic map.
Figure 2 summarizes the results of the two-point LOD
scores computed at each of the marker loci. Ten addi-
tional microsatellite markers were then genotyped on
chromosomes 1, 2, 3, 7, 11, 14, and 22, close to markers
with the highest LOD scores, to increase the informa-
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tion content of these loci in the multipoint linkage anal-
ysis. Three regions—located on chromosomes 22q12,
2q24, and 2q35—yielded maximum multipoint LOD
scores 10.83 ( ), with LOD scores of 2.9, 1.45,P ! .025
and 0.97, respectively (table 2). Two additional regions
(14q13-14q23 and 2q27-3qter) provided lower LOD
scores that were slightly below 0.83 (data not shown).
All other regions provided LOD scores !0.73 ( ).P 1 .03
In the second step of the genetic analysis, the three
regions that presented suggestive linkage with KA (LOD
score 0.83 [ ]) were further investigated byP  .025
typing 25 additional families (table 2) and 13 additional
markers: five microsatellites were typed at both the
22q12 and 2q23-2q24 loci, to provide a 2–3-cM map
of these two regions, and three NRAMP1 gene poly-
morphisms were typed at chromosome 2q35. In the lat-
ter analysis, LOD scores in region 22q12 increased
to 3.50 ( ) at marker D22S280 (table 2;5Pp 3# 10
fig. 3). This locus is significant on a genomewide basis
(Lander and Kruglyak 1995). Because our previous ep-
idemiological studies suggested that KA occurring late
in the outbreak developed against an immunological
background different from that of the early cases (Buch-
eton et al. 2003b), the analysis was also performed on
KA cases that occurred at the beginning of the outbreak
(before 1999). In this analysis, 52 of the 63 families
remained informative (with at least two affected chil-
dren). An increased maximum multipoint LOD score
of 3.90 ( ) was obtained for a position 0.5 cM5Pp 10
from the peak obtained when all KA cases were con-
sidered (fig. 3). The multipoint linkage analysis of the
two other chromosomal regions (2q23-q24 and 2q35)
yielded maximum multipoint LOD scores (1.53 and
0.79, respectively) similar to those in the first step (table
2). However, in an analysis performed on the 30 families
displaying negative LOD scores at D22S280, the
maximum multipoint LOD scores were increased to
2.29 at 2q23-q24 ( ) and were moderatelyPp .0006
increased to 1.00 at 2q35 ( ) with NRAMP1Pp .015
intragenic polymorphisms. The chromosomal position
of NRAMP1 is 61 cM from the D2S141 marker that
provides the maximum LOD score in the 2q23-q24
region.
Discussion
The present study shows a significant linkage of KA to
chromosome 22q12 and provides suggestive linkage re-
sults at a second locus on chromosome 2q23-q24. This
is the first report of a successful genome scan in human
leishmaniais (CL or KA); it supports the view that sus-
ceptibility to KA is determined by host genetics, as was
first indicated by animal studies (Blackwell 1996). Since
the spread of KA is known to be markedly dependent
on environmental conditions, the search for host genetic
factors in KA was thought to be a difficult task. Several
factors may have contributed to the success of the pres-
ent study: (i) it was performed in a population that ex-
perienced high transmission rates and the infection of a
large majority of the population during the outbreak,
thereby reducing the confounding effects of environ-
mental factors (Bucheton et al. 2002); (ii) the KA phe-
notype was defined according to stringent criteria (in
particular, the identification of the parasite on lymph
node smears was an absolute requirement for patient
inclusion); and (iii) the 5-year clinical and epidemiolog-
ical study that preceded our genome scan detected sev-
eral variables of heterogeneity in the population, in-
cluding the ethnic origin of the subjects. We have been
able to take these variables into account, thereby limiting
sample heterogeneity. Nevertheless, an important source
of heterogeneity that we could not control for was par-
asite diversity. During the epidemiological study, at least
seven different zymodemes (characterized by isoenzyme
electrophoresis) included in the three taxa L. donovani,
L. infantum, and L. archibaldi were isolated from pa-
tients with KA (Pratlong et al. 2001). For this reason,
we were concerned about the possibility that the search
for susceptibility loci would be hindered by the com-
plexity of the parasite population. This observation, as
well as the failure of segregation analysis to detect a
single major locus, led us to select the affected-sibling-
pair strategy. The high virulence of L. donovani was also
a major concern to us, since the possibility existed that
very pathogenic parasites might have the capacity to
overcome most genetic barriers. Finally, genetic control
had never been analyzed in acute epidemic conditions,
and there was concern that the genetic control might be
more difficult to detect in such conditions than in en-
demic conditions and chronic illnesses. Fortunately, none
of these factors hampered this genome scan or the dem-
onstration of the genetic control. Genomewide linkage
approaches have also been applied successfully in the
study of genetic susceptibility to other infectious dis-
eases. Levels of infection by Schistosoma mansoni are
linked to chromosome 5q31-q33 (Marquet et al. 1996).
In addition, two loci involved in susceptibility to lep-
rosy were recently mapped: one locus, on chromo-
some 10p13, is involved in paucibacillary forms of the
disease (Siddiqui et al. 2001), and another locus, on
chromosome 6q25, controls leprosy itself (Mira et al.
2003). Taken together, these results demonstrate that
genomewide approaches are valuable tools for the study
of host genetics in complex infectious diseases. They also
suggest that genetic susceptibility to infectious agents is
less complex than was previously thought and that ge-
netic variations at a single locus can significantly affect
the susceptibility of the host.
The proportions of alleles shared by affected siblings
in the region with the peak LOD score, 22q12, were
0.63 (all KA cases) and 0.66 (KA before 1999). The
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Figure 2 Primary genomewide linkage scan of 169 affected children belonging to 38 multicase nuclear families, using 377 microsatellite
markers. The two-point LOD score is shown on the vertical axis and the distance (in cM) from the p terminus of the chromosome is on the
horizontal axis.
locus-specific recurrence-risk ratios for siblings (ls)
(Risch 1990) were estimated to be 1.83 (all KA) and
2.11 (KA before 1999). ls values for many infectious
diseases are not expected to be very high, since ls cannot
be greater than 1/disease prevalence (in this outbreak
1/0.3 p 3.33). For example, ls for a major locus of
susceptibility to leprosy was 1.66 (Siddiqui et al. 2001).
Although it is possible that the ls was overestimated
because of an upward bias in the estimation of locus-
specific effects from genomewide scans (Go¨ring et al.
2001), the 22q12 locus identified here is likely to play
an important role in the genetic control of KA in this
population. The genotypic data from the 30 patients
who developed KA late in the outbreak (in 1999 and
2000) contributed little to the LOD score that mapped
a KA-susceptibility gene on chromosome 22q12. This
indicates that the control of KA in subjects affected early
in the epidemic may be different from that in subjects
affected later. This view is supported by the observation
that subjects affected late in the epidemic, unlike those
affected earlier, were found to control infection for sev-
eral years before the onset of clinical disease (Bucheton
et al. 2003b). Evidence of the genetic contribution to
host susceptibility to KA will be further increased if the
second locus can be confirmed, since our data suggest
a genetic heterogeneity, with a major locus on chro-
mosome 22q12 and another on chromosome 2q23-q24
(LOD score 2.29) in families with negative LOD scores
at the 22q12 locus. Suggestive linkage (LOD score 1.00)
was also seen with NRAMP1 intragenic markers (2q35),
which confirms our previous results obtained with a
smaller sample size (Bucheton et al. 2003). Thus, our
work suggests that NRAMP1, unlike its mouse hom-
olog, plays only a minor role in determining suscepti-
bility to KA. However, one should note that Nramp1
was shown to influence early control of parasite loads
in the spleens of mice experimentally infected with L.
donovani (Bradley et al. 1979), a phenotype that may
be different from the clinical phenotype studied here.
Furthermore, susceptibility was shown to be caused by
the Nramp1Asp169 functional null allele, and, although
allelic forms of the human NRAMP1 gene have been
shown to be associated with increased susceptibility to
various infectious or autoimmune diseases (Blackwell
et al. 2003), there is no evidence that such null alleles
of the NRAMP1 gene exist in human populations ex-
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Table 2
Results of the Linkage Analysis Performed on Families with Sibs Affected by KA
CHROMOSOMAL
REGION
AND MARKER
LOD SCORE (% INFORMATION CONTENT) IN
Primary Scan Refined Map Conditional Analysis
Single Point Multipoint Single Point Multipoint Single Point Multipoint
22q12:
D22S315 .97 (61) 1.54 (80) 1.07 (64) 1.77 (84) … …
D22S1167 … … .56 (38) 2.54 (81) … …
D22S1163 … … .97 (56) 2.44 (83) … …
D22S280 1.84 (59) 2.90 (82) 1.66 (56) 3.50 (86) … …
D22S424 … … .27 (34) 2.40 (86) … …
D22S277 … … .74 (72) 1.64 (92) … …
D22S283 .88 (87) 1.09 (96) 1.67 (84) 1.67 (95) … …
2q23-2q24:
D2S151 .40 (73) .44 (84) .67 (66) .72 (85) 2.19 (70) 2.27 (87)
D2S2275 … … 1.89 (47) 1.00 (87) 2.85 (42) 2.21 (88)
D2S2299 … … 1.23 (57) .99 (89) 1.62 (63) 1.75 (90)
D2S141 … … 2.14 (66) .86 (93) 3.74 (72) 2.29 (93)
D2S142 1.28 (71) 1.45 (83) 2.34 (70) 1.23 (93) 3.84 (71) 2.27 (94)
D2S284 … … .10 (50) .93 (88) .39 (50) 2.06 (87)
D2S156 … … .45 (65) .95 (87) 1.99 (69) 2.07 (87)
D2S2330 1.27 (63) 1.22 (82) 2.01 (58) 1.53 (81) 1.78 (62) 2.26 (81)
2q35:
D2S2382 1.15 (68) .97 (83) .84 (69) .79 (84) 1.70 (68) .95 (83)
5′(CA)n
a … … .60 (30) .77 (84) .17 (32) .98 (58)
46914G/Ca … … .21 (23) .73 (84) .38 (23) 1.00 (84)
172955 del4a … … .38 (22) .50 (86) .37 (24) .71 (87)
D2S1471 .25 (64) .31 (90) .07 (69) .18 (90) .14 (70) .50 (90)
NOTE.—Linkage results are shown for markers of three chromosomal regions (22q12-q13, 2q23-q24,
and 2q35) with LOD scores 10.83 ( ) in the primary screen of the genome conducted on a set ofP ! .025
38 families and for the whole family set (63 families). An analysis was performed on the 30 families displaying
negative LOD scores at D22S280. Linkage analyses were performed using the MLB model-free method
implemented in an extension of the Genehunter program.
a NRAMP1 intragenic polymorphisms.
posed to a wide range of intracellular pathogens. It is
noteworthy that a study of mice from wild natural pop-
ulations also failed to identify the null allele (Blackwell
1983).
The knowledge that KA is, in part, determined by a
major locus and possibly by a second locus is the first
step toward the identification of the disease suscepti-
bility genes and the characterization of the critical steps
in the pathological process involved in this lethal dis-
ease. The IL-2 receptor b chain gene (IL2RB), which is
located in the 22q12 chromosomal region close to
D22S280 microsatellite marker, is a good candidate for
the control of KA. IL-2 is critical for T-cell proliferation
and differentiation. T-cell responses are strongly sup-
pressed in patients with KA (Carvalho et al. 1981,
1985), and high levels of circulating soluble IL-2 recep-
tor have been observed during the acute phase of the
disease (Barral-Netto et al. 1991). Studies of other pro-
tozoa, such as Trypanosoma cruzi, also support the hy-
pothesis that some parasites evade the immune system
by acting on the IL-2 pathway (Majumder and Kier-
szenbaum 1996). In this regard, it is interesting to note
that two other genes—N-myc interactor (NMI [MIM
603525]) and signal transducing adapter molecule 2
(STAM2 [MIM 606244]), both located in the 2q22-q23
region—code for proteins involved in the IL-2 signaling-
transduction pathway.
These results raise the possibility that host suscepti-
bility alleles play a critical role in the control of disease
outbreaks. This view is supported by the marked dif-
ferences in susceptibility to KA among the three ethnic
groups of the village, differences that could not be as-
cribed by epidemiological factors (Bucheton et al. 2002).
It would be premature to draw conclusions at this stage
of the study; however, the identification of the suscep-
tibility alleles at the 22q12 locus and at other chro-
mosomal locations should allow studies that will lead
to stronger conclusions about the role of susceptibility
alleles in disease outbreaks.
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